---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-003940"
form_type: "8-K"
ticker: "CPRX"
cik: "0001369568"
company_name: "CATALYST PHARMACEUTICALS, INC."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:06:47.389680+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Catalyst Pharmaceuticals posts corporate presentation; no new material financial or business updates disclosed

## Summary
- Filed an 8-K on January 8, 2024, announcing a corporate presentation posted to its website for investor discussions.
- Presentation cover page and safe harbor language provided; no specific financial results, pipeline updates, or material events included.
- No earnings, M&A, leadership changes, debt, litigation, cyber, dividend, or regulatory actions reported in the filing.

## SEC filing metadata
- accession: 0001193125-24-003940
- form_type: 8-K
- ticker: CPRX
- cik: 0001369568
- company_name: CATALYST PHARMACEUTICALS, INC.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369568/000119312524003940/0001193125-24-003940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369568/000119312524003940/d108681d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-003940
- JSON: https://secwatch.observer/filing/0001193125-24-003940.json
- Plain text: https://secwatch.observer/filing/0001193125-24-003940.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.